These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization. Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925 [TBL] [Abstract][Full Text] [Related]
3. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide. Xu X; Zheng Y; Luo L; You Z; Chen H; Wang J; Zhang F; Liu Y; Ke Y Cell Death Dis; 2024 May; 15(5):318. PubMed ID: 38710703 [TBL] [Abstract][Full Text] [Related]
4. Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells. Noh H; Zhao Q; Yan J; Kong LY; Gabrusiewicz K; Hong S; Xia X; Heimberger AB; Li S Cancer Lett; 2018 Oct; 433():176-185. PubMed ID: 29991446 [TBL] [Abstract][Full Text] [Related]
5. Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase Hannen R; Selmansberger M; Hauswald M; Pagenstecher A; Nist A; Stiewe T; Acker T; Carl B; Nimsky C; Bartsch JW Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31262047 [TBL] [Abstract][Full Text] [Related]
6. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522 [TBL] [Abstract][Full Text] [Related]
7. BMP4 and Temozolomide Synergize in the Majority of Patient-Derived Glioblastoma Cultures. Verploegh ISC; Conidi A; El Hassnaoui H; Verhoeven FAM; Korporaal AL; Ntafoulis I; van den Hout MCGN; Brouwer RWW; Lamfers MLM; van IJcken WFJ; Huylebroeck D; Leenstra S Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337661 [TBL] [Abstract][Full Text] [Related]
8. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
9. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
10. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines. Lombardi F; Augello FR; Artone S; Gugu MK; Cifone MG; Cinque B; Palumbo P Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163465 [TBL] [Abstract][Full Text] [Related]
11. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells. Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410 [TBL] [Abstract][Full Text] [Related]
12. Unveiling the Pharmacological Role of Human Deubiquitinating Enzymes in Temozolomide Response of Glioblastoma Cells. Yang C; Li Y; Wu Q; Tang J; Chen M; Zhang B; Li B; Qin Y; Huang G; Zhang Y; Zhi F; Liu K Cell Biochem Biophys; 2024 Sep; 82(3):2183-2193. PubMed ID: 38809352 [TBL] [Abstract][Full Text] [Related]
13. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057 [TBL] [Abstract][Full Text] [Related]
14. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Kan W; Gao L; Chen J; Chen L; Zhang G; Hao B; He M; Chen X; Wang C Mol Neurobiol; 2024 Sep; 61(9):7066-7074. PubMed ID: 38368287 [TBL] [Abstract][Full Text] [Related]
15. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
16. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition. Liu T; Li A; Xu Y; Xin Y Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175 [TBL] [Abstract][Full Text] [Related]
17. TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma. Yu J; Gao G; Wei X; Wang Y BMC Cancer; 2022 Jul; 22(1):786. PubMed ID: 35850753 [TBL] [Abstract][Full Text] [Related]
18. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243 [TBL] [Abstract][Full Text] [Related]
19. LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma. Liu B; Zhou J; Wang C; Chi Y; Wei Q; Fu Z; Lian C; Huang Q; Liao C; Yang Z; Zeng H; Xu N; Guo H Cell Death Dis; 2020 May; 11(5):384. PubMed ID: 32439916 [TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis. Huang P; Zhang L; Wang H; Dou C; Ju H; Yue P; Ren J Neuropathology; 2024 Aug; 44(4):319-330. PubMed ID: 38448392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]